Initial and Follow-up Costs by Treatment Outcome for Children with Respiratory Infections

Pediatrics

Volumn 113, Issue 5 I, 2004, Pages 1352-1356

  Howard, David H ^a   McGowan Jr , John E ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Antibiotic use; Cost analysis; Otitis media

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; EAR INFECTION; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CONTINUITY OF PATIENT CARE; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; MALE; OTITIS MEDIA; RESPIRATORY TRACT INFECTIONS; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES;

EID: 2342453856     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.5.1352     Document Type: Article

References (23)

1. Elden LM, Coyte PC. Socioeconomic impact of otitis media in North America. J Otolayrngol. 1998;27:9-16
2. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 1997;278:901-904
3. McCraig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273: 214-219
4. Dixon RE. Economic costs of respiratory tract infections in the United States. Am J Med. 1985;78:45-51
5. Berman S, Byrns PJ, Bondy J, et al. Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric Medicaid population. Pediatrics. 1997;100:585-592
6. Kaplan B, Wandstrat TL, Cunningham JR. Overall cost in the treatment of otitis media. Pediatr Infect Dis J. 1997;16:S9-S11
7. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487-494
8. Bjerrum L, Dessau RB, Hallas J. Treatment failures after antibiotic therapy of uncomplicated urinary tract infections. Scand J Prim Health Care. 2002;20:97-101
9. Piccirillo JF, Mager DE, Frisse ME, et al. Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis. JAMA. 2001;286:1849-1856
10. Cohen JW, Monheit AC, Beauregard KM, et al. The Medical Expenditure Panel Survey: a national health information resource. Inquiry. 1996; 33:373-389
11. Yelin E, Trupin L, Cisternas M, Eisner M, Katz P, Blanc P. A national study of medical care expenditures for respiratory conditions. Eur Respir J. 2002;19:414-421
12. Selden TM, Levit KR, Cohen JW, et al. Reconciling medical expenditure estimates from the MEPS and the NHA, 1996. Health Care Financ Rev. 2001;23:161-177
13. Elixhauser A, Steiner CA, Whittington CA, McCarthy E. Clinical Classifications for Health Policy Research: Hospital Inpatient Statistics, 1995. Healthcare Cost and Utilization Project, HCUP-3 Research Note. Rockville, MD: Agency for Healthcare Research and Quality; 1999 (AHCPR Pub. No. 98-0049)
14. Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz, B. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics. 1998;101:163-165
15. Duan N, Manning WG, Morris CN, et al. A comparison of alternative models for the demand for medical care. J Bus Econ Stat. 1983;1:115-126
16. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc. 1983;78:605-610
17. Macfarlane JT, Colville A, Guion A, et al. Prospective study of aetiology and outcome of adult lower-respiratory tract infections in the community. Lancet. 1993;341:511-514
18. Davey P, Rutherford D, Graham B, Lynch B, Malek M. Repeat consultations after antibiotic prescribing for respiratory infection: a study in one general practice. Br J Gen Pract. 1994;44:509-513
19. Alsarraf R, Jung CJ, Perkins J, et al. Measuring the indirect and direct costs of acute otitis media. Arch Otolaryngol Head Neck Surg. 1999;125:12-18
20. Carabin H, Gyorkos TW, Soto JC, et al. Estimation of direct and indirect costs because of common infections in toddlers attending day care centers. Pediatrics. 1999;103:556-564
21. Garau J. The hidden impact of antibacterial resistance in respiratory tract infection. Clinical failures: the tip of the iceberg? Respir Med. 2001;95:S5-S11
22. Metlay JP, Singer DE. Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance. Clin Microbiol Infect. 2002;8:S1-S11
23. Klugman KP. The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxicillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. J Antimicrob Chemother. 1996;38:S133-S140